Correlation Between Sarthak Metals and Par Drugs

Can any of the company-specific risk be diversified away by investing in both Sarthak Metals and Par Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarthak Metals and Par Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sarthak Metals Limited and Par Drugs And, you can compare the effects of market volatilities on Sarthak Metals and Par Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarthak Metals with a short position of Par Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarthak Metals and Par Drugs.

Diversification Opportunities for Sarthak Metals and Par Drugs

-0.19

Correlation Coefficient

Sarthak Metals  Par Drugs

Good diversification

The 3 months correlation between Sarthak and Par is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Sarthak Metals Limited and Par Drugs And in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Par Drugs And and Sarthak Metals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarthak Metals Limited are associated (or correlated) with Par Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Par Drugs And has no effect on the direction of Sarthak Metals i.e., Sarthak Metals and Par Drugs go up and down completely randomly.

Pair Corralation between Sarthak Metals and Par Drugs

Assuming the 90 days trading horizon Sarthak Metals Limited is expected to under-perform the Par Drugs. In addition to that, Sarthak Metals is 1.2 times more volatile than Par Drugs And. It trades about -0.03 of its total potential returns per unit of risk. Par Drugs And is currently generating about 0.07 per unit of volatility. If you would invest  10,647  in Par Drugs And on April 24, 2025 and sell it today you would earn a total of  826.00  from holding Par Drugs And or generate 7.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Sarthak Metals Limited  vs.  Par Drugs And

Sarthak Metals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sarthak Metals Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Sarthak Metals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Par Drugs And

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Par Drugs And are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting technical and fundamental indicators, Par Drugs may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pair Trading with Sarthak Metals and Par Drugs

The main advantage of trading using opposite Sarthak Metals and Par Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarthak Metals position performs unexpectedly, Par Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Par Drugs will offset losses from the drop in Par Drugs' long position.

The idea behind Sarthak Metals Limited and Par Drugs And pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.